z-logo
Premium
Immunohistochemical study of palatal salivary glands of denture wearing patients
Author(s) -
Vigneswaran N.,
Hornstein O. P.,
Niedermeier W.,
Gruschwitz M.
Publication year - 1988
Publication title -
journal of oral pathology and medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.887
H-Index - 83
eISSN - 1600-0714
pISSN - 0904-2512
DOI - 10.1111/j.1600-0714.1988.tb01530.x
Subject(s) - pathology , sialadenitis , immunohistochemistry , salivary gland , ductal cells , carcinoembryonic antigen , cytokeratin , lactoferrin , medicine , biology , cancer , genetics
The binding pattern of antibodies against different cytokeratin (CK) polypeptides, tissue polypeptide antigen (TPA), carcinoembryonic antigen (CEA), lactoferrin (Lf), lysozyme (Ly) and secretory component (SC) in palatal glands (PSG) of long‐term denture wearing patients has been studied to investigate immunohistochemically the localization of these marker proteins in normal PSG and in denture‐induced sialadenitis of PSG. The study included palatal gland biopsies from 28 patients (15 f, 13 m; mean age 59 years), 17 of them with normal PSGs, 8 with focal obstructive sialadenitis, and 3 with diffuse sialadenitis. Presence of CK and TPA was found in all intra‐ and extraglandular salivary ducts, in the basophilic portions of acini, in some mucous acini, and in all atrophic acini. Increased expression of CEA and Lf was observed in inflammed areas of PSG which, on the other site, were devoid of Ly and SC. In the mucous acini of healthy PSG considerable basal Ly immunoreactivity was seen. SC was localized in almost all ductal cells and in some acinar cells. Appearance of Lf in the ductal cells of PSG indicates an early sign of palatal sialadenitis. Some distinctions in the expression pattern of the marker proteins between the mucous acini of major salivary glands and PSG point to differences in the functional activities of either group of salivary glands.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here